Experiment challenge for hypothesis: TREM2-mTOR Co-Agonism for Metabolic Reprogramming ## Mechanistic Hypothesis ## Mechanistic Overview TREM2-mTOR Co-Agonism for Metabolic Reprogramming starts from the claim that modulating TREM2-mTOR pathway within the disease context of neurodegeneration can redirect a disease-relevant process. The original description reads: "TREM2-mTOR Co-Agonism for Metabolic Reprogramming Mechanism of Action The triggering receptor expressed on myeloid cells 2, encoded by TREM2, functions as a critical metabolic checkpoint on microglia, the resident immune cells of the central nervo ## Target Gene/Pathway TREM2-mTOR pathway ## Disease Context neurodegeneration ## Evidence Supporting this Hypothesis [{'pmid': '28802038', 'claim': 'TREM2 maintains microglial metabolic fitness in AD through mTOR signaling'}, {'pmid': '28802038', 'claim': 'TREM2-deficient microglia have defective mTOR signaling with abundant autophagic vesicles'}, {'pmid': '35672148', 'claim': 'Microglial mTOR activation upregulat ## Evidence Against / Caveats [{'pmid': '28802038', 'claim': 'mTOR activation inhibits autophagy; TREM2-deficient microglia accumulate autophagic vesicles but mTOR activation may exacerbate this accumulation by blocking autophagic ## Composite Score 0.803 (mechanistic plausibility: 0.52, feasibility: 0.22, impact: 0.65, confidence: 0.60)